New insights on molecular biology and markers

• OC 11-01 • Clinical performance of gyntect-methylation markers for triage HPV-positive women See abstract > M. Martina Schmitz • OC 11-02 • Genome-wide methylome analysis uncovers new hypermethylation biomarkers for both adeno- and squamous cell cervical carcinoma See abstract > R. Roland Van Leeuwen • OC 11-03 • PERFORMANCE OF CADM1/MAL-METHYLATION ANALYSIS FOR MONITORING WOMEN TREATED FOR HIGH-GRADE CIN See abstract > M. Marjolein Van Zummeren • OC 11-04 • Effects of HPV 16 E6 and E7 on genomic stability in HCT116 cells See abstract > L. Lennard Ganss • OC 11-05 • P16INK4A immunohistochemistry / HPV DNA PCR co-testing identifies HPV-induced anal squamous cell carcinomas with high diagnostic accuracy See abstract > T. Theresa Obermueller • OC 11-06 • Characterization of cervical lesions by expression analysis of p16 and Stathmin See abstract > N. Nora Nevermann • OC 11-07 • P16/Ki-67 dual-stained cytology for detecting cervical (pre)cancer in a HPV-positive gynecologic outpatient population See abstract > R. Roosmarijn Luttmer • OC 11-08 • 16/Ki-67 as a triage test routine: correlation with histology See abstract > A. Arjola Xhaja • OC 11-09 • Combined biomarker expression patterns of panHPVE4 and p16INK4a can support the diagnosis and grading of CIN See abstract > A. Anco Molijn • OC 11-10 • High sensitivity proteomic analysis reveals novel pathways and key regulators in the pathology of cervical cancer See abstract > K. Kalliopi Pappa • OC 11-11 • Performance of a New HPV and Biomarker Assay in the Management of High Risk HPV Positive Cases See abstract > A. Adrienn Kocsis • OC 11-12 • Tracing HPV DNA integration sites during the development of the pre-cancerous lesions of the cervix See abstract > K. Katrin Carow • OC 11-13 • Metabolomics of cervical cancer cell lines document discrete profiles and reveal novel metabolites with HPV-specific features See abstract > N. Nicholas Anagnou • OC 11-14 • Beneficial effects of of a coriolus versicolor-based vaginal gel on cervical epithelization, vaginal microbiota and vaginal health: a pilot study in asymptomatic women See abstract > D. Damian Dexeus • OC 11-15 • Cervical microbiota as a possible modulator of the cytokine profile at the cervical microenvironment in cervical lesions and cervical cancer See abstract > K. Kirvis Janneth Torres-Poveda • OC 11-16 • Cervical Antimicrobial Peptides Are Decreased Following Excisional Treatment for Cervical Intraepithelial Neoplasia See abstract > A. Anita Mitra • OC 11-17 • Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2/3 lesions See abstract > D. Danielle Heideman • OC 11-18 • Tumor specific imaging in HPV16 positive cervical cancer using HPV16-E7 binding affibody molecules See abstract > L. Lifang Zhang